Podcast: Healthcare Delivery in the Wake of COVID-19

July 30, 2020 | A New Podcast About COVID-19's Impacts on Healthcare


Ashfield Capital Partners is committed to delivering interesting, relevant and timely insights. As people around the globe focus on recovery and treatment for COVID-19, one area we have found to be especially impactful during this time is healthcare.

In our premiere podcast episode, Ashfield Capital Partners Chief Compliance Officer and Portfolio Manager Adrian Fadrhonc talks with Sylvie Boulva MHS, PA-C, a Physician Assistant at the University of Utah’s Division of Pediatric Rheumatology and Urgent Care Clinic. During their candid conversation, Boulva provides an inside look at healthcare delivery and technologies during COVID-19, including the pandemic’s potential short-term and long-term effects on the industry. Specifically, Fadrhonc and Boulva discuss:

  • How healthcare providers can successfully transition to pandemic delivery methods
  • Which healthcare behaviors might remain after the pandemic
  • The benefits and limitations of digital healthcare screenings
  • The best American healthcare delivery developments in the past 5-10 years
  • How healthcare professionals are teaching patients about new technologies
  • The importance of shifting the perspective about what “good healthcare” really means

You can listen to Fadrhonc and Boulva’s entire conversation here. You can also read our recent article on the transformation of healthcare here.

This communication is intended to highlight various market and economic information and is not intended to interpret laws or regulations. This communication has been prepared solely for informational purposes, based upon information generally available to the public from sources believed to be reliable, but no representation or warranty representation, express or implied, has been made as to the accuracy or completeness of the information contained herein and is not an offer to buy or sell or a solicitation of an offer to buy or sell any security or to participate in any trading strategy. If any offer of securities is made, it will be pursuant to a confidential offering memorandum, an investment management agreement or other offering materials, which contains material information not contained herein and which supersedes this information in its entirety. This communication is not designed to be a comprehensive analysis of any topic discussed herein and should not be relied upon as the only source of information. Additionally, this communication is not intended to represent advice or a recommendation of any kind, as it does not consider the specific investment objectives, financial situation, applicable risk factors, and/or particular needs of any individual client or investor and should not be relied upon as the basis for investment decisions. Additional information is available upon request.